Zura Bio - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeZura Bio
Zura Bio logo

Zura Bio

0 followers

ZURA

Performance

About Zura Bio

Zura Bio is a biotechnology company focused on developing novel medicines for serious immune system disorders, with a portfolio targeting autoimmune and inflammatory conditions. The company emphasizes dual-pathway biology to address unmet needs beyond single-pathway therapies, aiming to deliver differentiated treatments across its therapeutic areas. Led by biotechnology entrepreneurs and pharma veterans, Zura Bio is advancing tibulizumab (ZB-106), crebankitug (ZB-168), and torudokimab (ZB-880) with a focus on efficacy, safety, and dosing convenience. The organization is headquartered in Henderson, Nevada, USA, and engages with investors and patients through its pipeline and research updates.

Recent News

No recent news for this company.

Recent Deals

Key Team Members

Sandeep Kulkarni, MD

Co-Founder, Chief Executive Officer and Director

Eric Hyllengren

Chief Financial Officer

Gary Whale, PhD

Chief Technology Officer

Key Facts

HQ Location

Henderson, United States

Founded

2022

Employees

11 - 50

Status

Public

Website

https://zurabio.com